A Randomized, Placebo- Controlled Study to Evaluate the Efficacy of Itopride HCl in Patients of Irritable Bowel Syndrome With Constipation (IBS-C).

Trial Profile

A Randomized, Placebo- Controlled Study to Evaluate the Efficacy of Itopride HCl in Patients of Irritable Bowel Syndrome With Constipation (IBS-C).

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2013

At a glance

  • Drugs Itopride (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
    • 29 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top